These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 35734396)
1. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Pu D; Zhang Z; Feng B Front Pharmacol; 2022; 13():906419. PubMed ID: 35734396 [TBL] [Abstract][Full Text] [Related]
2. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease? Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114 [TBL] [Abstract][Full Text] [Related]
3. Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future Challenges. Zatorski H; Nakov R Curr Drug Targets; 2020; 21(14):1440-1447. PubMed ID: 32484770 [TBL] [Abstract][Full Text] [Related]
4. Cross-talk between macrophages and gut microbiota in inflammatory bowel disease: a dynamic interplay influencing pathogenesis and therapy. Ning S; Zhang Z; Zhou C; Wang B; Liu Z; Feng B Front Med (Lausanne); 2024; 11():1457218. PubMed ID: 39355844 [TBL] [Abstract][Full Text] [Related]
5. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches. Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081 [TBL] [Abstract][Full Text] [Related]
6. Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease. Zhang X; Ishikawa D; Ohkusa T; Fukuda S; Nagahara A Front Med (Lausanne); 2022; 9():1068567. PubMed ID: 36530877 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711 [TBL] [Abstract][Full Text] [Related]
8. Faecal microbiota transplantation: looking beyond clostridium difficile infection at inflammatory bowel disease. Patel K; Patel A; Hawes D; Shah J; Shah K Gastroenterol Hepatol Bed Bench; 2018; 11(1):1-8. PubMed ID: 29564058 [TBL] [Abstract][Full Text] [Related]
9. Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease. Tsai YC; Tai WC; Liang CM; Wu CK; Tsai MC; Hu WH; Huang PY; Chen CH; Kuo YH; Yao CC; Chuah SK J Microbiol Immunol Infect; 2024 Oct; ():. PubMed ID: 39393964 [TBL] [Abstract][Full Text] [Related]
10. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization. Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382 [TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review. Wang C; Gu Y; Chu Q; Wang X; Ding Y; Qin X; Liu T; Wang S; Liu X; Wang B; Cao H Microbiol Res; 2024 May; 282():127660. PubMed ID: 38442454 [TBL] [Abstract][Full Text] [Related]
14. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Weingarden AR; Vaughn BP Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251 [TBL] [Abstract][Full Text] [Related]
15. Gut microbiota in the pathogenesis of inflammatory bowel disease. Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689 [TBL] [Abstract][Full Text] [Related]
16. Dual-targeted treatment for inflammatory bowel disease: Whether fecal microbiota transplantation can be an important part of it. Zhang ZN; Sang LX World J Gastroenterol; 2024 Sep; 30(36):4025-4030. PubMed ID: 39351254 [TBL] [Abstract][Full Text] [Related]
18. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Khan I; Ullah N; Zha L; Bai Y; Khan A; Zhao T; Che T; Zhang C Pathogens; 2019 Aug; 8(3):. PubMed ID: 31412603 [TBL] [Abstract][Full Text] [Related]
19. Spinal anesthesia alleviates dextran sodium sulfate-induced colitis by modulating the gut microbiota. Hong Y; Zhao J; Chen YR; Huang ZH; Hou LD; Shen B; Xin Y World J Gastroenterol; 2022 Mar; 28(12):1239-1256. PubMed ID: 35431512 [TBL] [Abstract][Full Text] [Related]
20. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice. Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]